Related Experiment Video
Updated: May 16, 2025
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Phenotype-Based Classification of Obstructive Hypertrophic Cardiomyopathy Undergoing Myectomy
Hao Cui1, Hao Nie2, Congrui Wang1
1The Cardiomyopathy Research Group, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing China; Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Animal Experimental Centre, Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Researchers identified three obstructive hypertrophic cardiomyopathy subtypes using clinical data. These subtypes differ in genetic mutations, atrial fibrillation prevalence, and risk of adverse events after treatment.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Obstructive hypertrophic cardiomyopathy (HCM) is a complex condition.
- Identifying distinct patient subtypes is crucial for personalized treatment.
Purpose of the Study:
- To classify obstructive HCM patients into distinct subtypes based on clinical and pathological data.
- To understand the unique characteristics of each identified subtype.
Main Methods:
- Analysis of clinical and pathological variables in patients undergoing septal reduction therapy.
- Partitioning of data to identify distinct patient groups.
- Validation of findings in two independent cohorts.
Main Results:
- Subtype 1: High sarcomere mutation carriers, maximal interventricular septal thickness.
- Subtype 2: Left atrial enlargement, high prevalence of atrial fibrillation.
- Subtype 3: High left ventricular outflow tract gradient, significant inflammation, increased adverse events post-therapy.
Conclusions:
- Distinct obstructive HCM subtypes have been identified.
- These subtypes are characterized by specific genetic, structural, and clinical features.
- Findings were robustly validated, supporting clinical relevance for patient stratification and management.
